Gen Digital Inc. — FY2024 Form 10-K
Reporting period: Fiscal year ended March 29, 2024, a 52-week year. Although the request metadata refers to 2023 Q4, this filing reports annual fiscal 2024 results, not a standalone quarterly period. All financial amounts below are in U.S. dollars.
Business context
Gen sells subscription-based cybersecurity, identity-protection and privacy products under brands including Norton, Avast, LifeLock, Avira, AVG, ReputationDefender and CCleaner. It reported approximately 500 million total users and 65 million paid cyber-safety customers, including 39.1 million direct customers. Avast was acquired in September 2022, so FY2024 includes a full year of Avast revenue versus a partial year in FY2023.
Financial performance
| Metric | FY2024 | FY2023 | Change |
|---|---|---|---|
| Net revenue | $3,812 million | $3,338 million | Up 14% |
| Gross profit | $3,081 million | $2,749 million | Up 12% |
| Gross margin | 80.8% | 82.4% | Down 1.6 percentage points |
| Operating income | $1,122 million | $1,227 million | Down 9% |
| Operating margin | 29.4% | 36.8% | Down 7.4 percentage points |
| Net income | $616 million | $1,349 million | Down 54% |
| Diluted EPS | $0.96 | $2.16 | Down 56% |
| Cash from operations | $2,064 million | $757 million | Up $1,307 million |
| Cash and cash equivalents | $846 million | $750 million | Up $96 million |
Revenue growth reflected an additional five and a half months of Avast contribution, higher consumer security and identity-protection sales, and $25 million of foreign-exchange headwinds. Consumer security revenue was $2,417 million and identity and information protection revenue was $1,332 million. Direct customer revenue was $3,353 million; direct customers reached 39.1 million, monthly direct ARPU was $7.25, and retention was 77%, compared with $7.10 and 76% in FY2023.
Margins and earnings declined despite revenue growth. Management attributed operating-income pressure primarily to higher legal accruals and acquired-intangible amortization, partly offset by revenue growth and acquisition synergies. General and administrative expense rose to $604 million from $286 million, including a $388 million increase in legal accruals. Interest expense increased to $669 million from $401 million. FY2023 net income benefited from a substantial tax benefit associated with a capital loss; FY2024 also included a tax benefit from legal-entity restructuring.
Cash, debt and liquidity
- Operating cash flow was $2,064 million; the filing says the increase was driven mainly by an $899 million tax refund related to the FY2023 return and collections from Avast revenue. The cash-flow increase should therefore not be read as solely reflecting recurring operating improvement.
- Cash used in investing activities was $2 million, versus $6,547 million used in FY2023, when Avast was acquired. Cash used in financing activities was $1,961 million.
- Outstanding debt principal was $8,716 million: $6,110 million in term loans, $2,600 million in senior notes and $6 million in mortgages. Balance-sheet debt, net of unamortized issuance costs, was $8,604 million. The $1,500 million revolving facility was undrawn; debt covenants were met at year-end.
- Cash dividends paid were $323 million, and the company repurchased 21 million shares for $441 million and made $1,183 million in debt repayments. A new repurchase authorization of up to $3 billion was approved in May 2024. A $0.125-per-share dividend was also announced for June 2024.
- Management expects cash, operating cash generation and available revolver capacity to cover working capital, ongoing operations, expected Avast synergy costs and known contractual obligations for at least the next 12 months. Contractual obligations include $2,438 million of estimated debt interest payments; long-term income taxes payable of $1,346 million were excluded from that obligations table because settlement timing could not be reliably estimated.
Material changes, outlook and key risks
- Acquisition and restructuring: Avast contributed to revenue growth and expanded international reach. The company had incurred $125 million under its September 2022 integration plan by year-end, against expected total costs of up to $150 million; actions are expected to finish by FY2025.
- Litigation: Gen accrued approximately $583 million for the Columbia University patent case after an enhanced judgment; its appeal remains pending, and additional loss is reasonably possible but not estimable. In the GSA matter, Gen accrued $53 million following an amended judgment; the judgment was not final and appeal options were under assessment.
- Taxes: Gen received $901 million of the $954 million in federal and state tax refunds claimed for a prior-year capital-loss carryback. The claims remain subject to tax-authority review, and repayment could be required if the company does not prevail. Gross unrecognized tax benefits were $1,163 million; accrued interest and penalties were $225 million.
- Other contingencies: Avast’s Jumpshot-related privacy matters include a Czech data-protection fine of CZK 351 million, affirmed in April 2024, and proposed or filed collective actions for which potential losses were not estimable. Gen reported a non-material FTC settlement agreement subject to Commission approval.
- Business risks: The filing highlights competition, customer retention and conversion of freemium users, cybersecurity and privacy regulation, AI-related legal and reputational exposure, foreign-exchange and interest-rate volatility, and dependence on Broadcom for certain Norton threat-response engineering services. No material information-security breach was reported for the prior three fiscal years.
- Guidance: The supplied filing text does not provide a clear quantified revenue or earnings forecast. Management describes a long-term focus on profitable growth, customer reach, cross-selling and retention; these are strategic priorities, not specific financial guidance.
KPMG issued an unqualified opinion on the financial statements and internal control over financial reporting. Management also concluded disclosure controls and internal control over financial reporting were effective as of March 29, 2024.
Investor facts to verify
- Progress and final cash exposure in the Columbia appeal and GSA litigation, including any amounts beyond existing accruals.
- Collection, audit outcomes and potential repayment exposure for the tax refund claims; changes in unrecognized tax benefits and related interest or penalties.
- Whether operating cash flow remains strong after the unusually large tax refund and the full-year contribution from Avast.
- Debt repayment capacity, refinancing terms and sensitivity to variable rates; the filing estimates a 100-basis-point SOFR increase would raise annual interest expense by $61 million before considering hedges.
- Whether customer growth, ARPU and retention gains continue, and whether Avast integration delivers expected savings within the stated cost and timing estimates.
- Use of the new $3 billion repurchase authorization and sustainability of dividends alongside debt reduction and other cash needs.